Authorised Representative Service
A manufacturer established outside Türkiye or EU member states cannot place its device on the market without appointing an authorised representative

Authorised Representative Service: Authorisation Document Content and UTS Registration
A device made by a manufacturer established outside Turkey or the EU Member States cannot be placed on the market without an authorised representative being appointed. That is why companies working with overseas manufacturers often receive the offer: "Be our representative in Turkey." Before accepting, it is important to know that this status is not a commercial title but a set of obligations defined in the regulation, and a position that carries joint liability. This page explains how the authorisation document is set up, which tasks can actually be delegated, and where we stand.
When an authorised representative becomes mandatory
The obligation depends on where the manufacturer is established, and it is defined in one sentence. Article 11, first paragraph of the Medical Device Regulation states that where the manufacturer is not established in Turkey or in an EU Member State, the device may be placed on the market only if the manufacturer has appointed an authorised representative.
The reverse is also defined, which prevents an unnecessary representative structure from being set up. Article 12, seventh paragraph, point (d) of the Guide explicitly states that manufacturers established in an EU Member State or in Turkey cannot appoint an EU authorised representative; the EU authorised representative requirement applies only to manufacturers not established in an EU Member State or in Turkey.
In practice, the first thing we check is this: not the manufacturer's invoicing address, but the country where it is established in the regulatory sense. For a German manufacturer, trying to fill in the "EU Authorised Representative" field in UTS is not a problem to solve; it is a wrong assumption.
An authorised representative and an importer are not the same role
Both roles are economic operators, but their sets of obligations differ, and if the same company holds both, it is subject to two separate lists of obligations.
- Authorised representative: Article 4, point (uuu) of the Guide defines the authorised representative as a natural or legal person established in Turkey or an EU Member State, appointed in writing by a manufacturer that is not established in Turkey or an EU Member State, to carry out certain obligations under the Medical Device Regulations on its behalf.
- Importer: Point (çç) of the same article defines the importer as a natural or legal person established in Turkey who places a device from another country on the Turkish market.
- Common umbrella: Point (v) of the same article treats an economic operator as a manufacturer, authorised representative, importer, distributor or SİP manufacturer.
The difference lies in the definition itself. The importer places the device on the market in its own name; the authorised representative carries out part of the manufacturer's obligations on its behalf. The first is a commercial position, the second is a mandated appointment in the nature of an agency.
When an appointment takes effect
An oral agreement or an email exchange does not count as an appointment. Article 11, second paragraph of the Medical Device Regulation states that the appointment of an authorised representative takes effect when an authorisation document is issued and accepted in writing by the authorised representative. The same paragraph provides that the authority covers, at a minimum, all devices in the same generic device group. So a representative cannot be given for a single reference number.
The content of the authorisation document is also prescribed. Article 11, third paragraph of the same Regulation states that the authorised representative will carry out the tasks specified in the authorisation document, will provide a copy of the authorisation document to the Institution on request, and that the authorisation document must cover at least the following tasks.
- Verification: verifying that the EU declaration of conformity and the technical documentation have been drawn up by the manufacturer and, where required, that an appropriate conformity assessment procedure has been carried out.
- Retention: keeping a copy of the technical documentation and the EU declaration of conformity, together with the relevant certificate issued under Article 56, including amendments and supplements where applicable, available to the Institution for the period referred to in Article 10, eighth paragraph.
- Registration obligations: complying with the registration obligations set out in Article 31 and verifying that the manufacturer complies with the registration obligations set out in Articles 27 and 29.
- Provision of information and documents: on request by the Institution, providing all information and documents needed to demonstrate the conformity of a device, in Turkish and/or in an official EU language accepted by the Institution.
- Samples and access: forwarding the Institution's requests for samples or access to a device to the manufacturer, and confirming that the Institution has received the samples or obtained access to the device.
- Cooperation: cooperating with competent authorities on corrective or preventive actions taken to eliminate the risks posed by devices or, where this is not possible, to mitigate them.
- Complaint transfer: informing the manufacturer promptly about complaints and reports from health professionals, patients and users concerning suspected adverse events relating to a device for which they have been appointed.
- Termination authority: terminating the authorisation document if the manufacturer acts contrary to its obligations under this Regulation.
The same paragraph also states that the manufacturer must enable the authorised representative to carry out these tasks. So a representative structure with no access to the technical documentation is not set up in line with the regulation, even if the contract says so.
Obligations the manufacturer cannot delegate
This is the boundary we most often explain to companies receiving representative offers. Article 11, fourth paragraph of the Medical Device Regulation states that under the authorisation document the manufacturer cannot delegate the obligations set out in the first, second, third, fourth, sixth, seventh, ninth, tenth, eleventh and twelfth paragraphs of Article 10.
This means that the expectation "I will hand everything over to the representative" has no basis in the regulation. The core obligations of the manufacturer, concerning design, production, technical documentation, risk management and post-market surveillance, remain with the manufacturer. The authorised representative does not take them on; it performs the tasks listed in the third paragraph.
Looked at from the other side, this also protects the company that would act as representative. A contract clause saying "all obligations of the manufacturer are transferred" has no legal effect under the regulation, but it creates expectations. When drafting the contract, these distinctions need to be made clearly.
The risk the representative carries: joint liability
An authorised representative is a risk item as much as a commercial one. Article 11, fifth paragraph of the Medical Device Regulation states that, without prejudice to the fourth paragraph, where the manufacturer does not comply with the obligations set out in Article 10, the authorised representative is legally jointly liable with the manufacturer on the same basis for defective devices.
The sentence contains a critical asymmetry: when the manufacturer fails to comply with an obligation it could not delegate, the representative is also held jointly liable for a defective device. The consequence of a breach of an obligation that was not delegated also falls on the representative.
For this reason, the first work we do before taking on a representative role is not writing a contract but reviewing: whether the manufacturer's conformity assessment file is complete, whether its certificates are valid, whether its quality management system is working, and whether post-market surveillance records exist. An authorisation document signed without these checks is not a commercial agreement; it is an open-ended liability commitment.
Does an authorised representative need a regulatory compliance person?
Yes, but in a different form from the manufacturer. Article 15, sixth paragraph of the Medical Device Regulation states that authorised representatives will obtain, on a permanent and continuous basis, the services of at least one person responsible for regulatory compliance with expertise in regulatory requirements for medical devices. The obligation is defined as obtaining such services on a permanent and continuous basis, not as keeping such a person in-house.
The rule for the manufacturer is different. The first paragraph of the same article provides that manufacturers will keep at least one person responsible for regulatory compliance with the necessary expertise in medical devices within their organisation, and lists the qualifications by which the necessary expertise is proven.
The exception is on the manufacturer side. The second paragraph of the same article states that micro and small enterprises under the Regulation on the Definition, Qualifications and Classification of Small and Medium-Sized Enterprises need not keep a regulatory compliance person within their organisation, but must obtain the services of such a person on a permanent and continuous basis in the manner set by the Institution.
The scope of the compliance person's role is also defined. The third paragraph of the same article states that the regulatory compliance person will at a minimum be responsible for checking the conformity of devices, for preparing and keeping up to date the technical documentation and the EU declaration of conformity, for compliance with post-market surveillance obligations, and for fulfilling reporting obligations. The fifth paragraph provides that this person, whether or not an employee of the organisation, will not be subject to any adverse treatment related to the proper performance of their duties.
The authorisation document you should ask the overseas manufacturer for
On the UTS side, the authorisation document corresponds to a concrete upload field, and the content it accepts is defined. Article 12, seventh paragraph, point (a) of the Guide states that for devices whose manufacturers are not established in an EU Member State or in Turkey, entry in the "EU Authorised Representative" field of the UTS registration screen is mandatory in the EU Declaration of Conformity notification.
- Agreement or authorisation document: point (b) of the same paragraph provides that the agreement and/or authorisation document concluded between the manufacturer company and the EU authorised representative will be uploaded to the "Authorisation Document" field that appears under the "EU Authorised Representative" field.
- EUDAMED output: the same point states that, as an alternative, the output of the actor screen on the EUDAMED website for the manufacturer concerned, in which the details of that EU authorised representative are clearly visible, may also be uploaded.
- Original and translation: point (c) states that the original document and a Turkish translation by a sworn translator will be uploaded together to the "Authorisation Document" field.
Physical submission is not required here either. Point (ç) of the same paragraph provides that the document uploaded to the "Authorisation Document" field does not also need to be sent physically to the Institution.
Is apostille required on the authorisation document?
No, and this is a notable exception within the document approval rules in UTS. Point (c) of Article 12, seventh paragraph of the Guide states explicitly that no apostille or embassy or consulate endorsement is required on the original of the authorisation document. The mandatory endorsement routes defined for certificates and declarations of conformity do not apply to the authorisation document.
The second relief concerns translation. The first sub-point of the same point provides that where an EUDAMED output has been uploaded to this field, it is not necessary to upload a sworn Turkish translation of that output together with it. So if the manufacturer's EUDAMED actor registration is in order, the authorisation document part becomes the lightest item in document preparation.
Difference between an authorised distributor certificate and an authorisation document
The two documents have similar names but do different jobs, and they carry different levels of obligation.
- Definition: point (ttt) of Article 4 of the Guide and the first paragraph of Article 23 define the Authorised Distributor Certificate as a document issued by the manufacturer of the device on behalf of an importer company operating in our country, stating that the importer company concerned is authorised in Turkey for the devices covered by the document.
- Not mandatory: the ninth paragraph of Article 23 of the Guide states that this document is not a mandatory document to be uploaded to UTS, and that if the document registration falls into a rejected state for any reason, the devices linked to the document will remain registered.
- Content is checked: the second paragraph of the same article states that the document must contain the manufacturer's name or trade name and address, the name or trade name and address of the authorised company, the product scope, the start date and, where applicable, the end date of the authorisation, and the signature and stamp of the manufacturer's authorised person; the second paragraph provides that these are fields checked during document review in UTS.
- Where the scope is not detailed: the third paragraph, point (a), states that where the document does not describe the product scope in detail, or covers all the manufacturer's products, "All Products" will be written in the "Original Language Product Scope" field and "Tüm Ürünler" in the "Turkish Product Scope" field.
In short: the authorised distributor certificate declares a commercial authorisation and is optional in UTS; the authorisation document certifies the appointment of an authorised representative under Article 11 of the Medical Device Regulation and is mandatory for the EU Declaration of Conformity notification of a manufacturer outside the EU.
What the contract must contain when a representative changes
When a representative changes, a handover structure with no gaps is needed, and its minimum content is set out. Article 12, first paragraph of the Medical Device Regulation states that detailed arrangements for changing the authorised representative will be clearly defined in a contract between the manufacturer, the newly appointed authorised representative and, where applicable, the previous authorised representative, and lists four matters the contract must address at a minimum.
- Dates: the date on which the authorisation document of the previous authorised representative is terminated and the start date of the authorisation document of the newly appointed authorised representative.
- Transition of materials: the latest date on which the previous authorised representative may be named on information supplied by the manufacturer, including promotional materials.
- Transfer of documents: the transfer of documents, including confidentiality principles and property rights.
- Transfer of complaints: the obligation of the previous authorised representative, after the end of its authorisation document, to forward to the manufacturer or to the newly appointed authorised representative any complaints or reports from health professionals, patients or users concerning suspected adverse events relating to a device for which it had been appointed as authorised representative.
The termination chain is also defined. Point (g) of the third paragraph of Article 11 of the Medical Device Regulation provides that the authorised representative will terminate the authorisation document if the manufacturer acts contrary to its obligations under this Regulation, and the sixth paragraph of the same article provides that an authorised representative terminating the authorisation on this ground must promptly notify the Institution and, where applicable, the notified body involved in the conformity assessment of the device, of the termination and the reasons.
The room a representative gives in free sale certificates
The authorised representative structure opens a concrete door on the export side. The first paragraph of Article 41 of the Guide states that the Institution issues the free sale certificate for export purposes, at the request of a domestic manufacturer or an EU authorised representative of a foreign manufacturer established in Turkey. There is no way to request this certificate as an importer.
The route for the application is also different. The third paragraph of Article 42 of the Guide provides that the free sale certificate application for devices of manufacturers established in Turkey, where the EU authorised representative is established in Turkey, must be made by the EU authorised representative concerned, which must be registered in UTS with the activity field type "manufacturer/importer/distributor/exporter", by petition to the Institution through EBS. The process run from the domestic manufacturer's UTS screen then returns to the petition route.
The same paragraph provides that the petition and its annexes will include the number of English copies, the country to which the certificate will be sent, the request for a Turkish copy, and a product list file containing the barcode numbers and the English product names of the devices. The second sub-point of point (ç) of the same paragraph requires that the English product names match exactly the Turkish product names in UTS.
SRN and the EUDAMED side
The European counterpart of the representative structure is the Single Registration Number. Point (rr) of Article 4 of the Guide defines the Single Registration Number (SRN) as the single registration number generated by EUDAMED for allocation to a manufacturer, an authorised representative or an importer.
The field in which this number is entered in UTS is also defined. Sub-point (ç) of point (b) of the second paragraph of Article 7 of the Guide states that, if the manufacturer's Single Registration Number is already given on the EU certificate, it is one of the fields that must appear on the certificate, and it is entered in UTS in the "Unique Identity No" field. The first sub-point of point (b) of the same paragraph provides that manufacturers established outside the EU Member States and Turkey must appoint an authorised representative from Turkey or an EU Member State in order to place devices on the EU market, and that the details of that representative must appear on the EU certificate.
Article 31, second paragraph of the Medical Device Regulation states that after the Institution verifies the entered data, it will send the single registration number provided by the electronic system to the manufacturer, the authorised representative or the importer. The third paragraph provides that the manufacturer will use this number when applying to a notified body for conformity assessment.
Scope of the service and its limits
Our scope is on the registration and document side. From your company page in UTS, you grant us the "Medical Device Registration Officer" authority; we establish the manufacturer's residence status, have the authorisation document prepared in the form UTS requires, choose which route, EUDAMED output or authorisation document, will involve fewer papers, correctly complete the "EU Authorised Representative" and "Unique Identity No" fields, and create the document application.
What we do not do is also clear. We do not grant the authorised representative status: under Article 11, second paragraph of the Medical Device Regulation, appointment arises from the authorisation document issued by the manufacturer and the representative's written acceptance. The joint liability under Article 11, fifth paragraph of the same Regulation falls on the company that takes on the representative status and cannot be transferred by consultancy. The electronic signature on applications remains with your company's signatory, and the accuracy of the data entered in UTS remains your company's responsibility.
If you have received a representative offer from an overseas manufacturer, the first thing we do before any contract is written is this: lay out the manufacturer's document set and compliance status in front of you, so that you can see the size of the responsibility you would take on.
